Thiazolidinedione associated volume overload and pulmonary hypertension

Therapeutic Advances in Cardiovascular Disease

Volumn 2, Issue 6, 2008, Pages 435-438

  Michaelson, Jeffrey ^a  

^a NONE   (United States)

Author keywords

Diabetes mellitus; Drugs; Echocardiography; Heart failure; Pulmonary hypertension

Indexed keywords

AMLODIPINE BESYLATE; FEXOFENADINE; FUROSEMIDE; GLIPIZIDE; GLITAZONE DERIVATIVE; LOSARTAN POTASSIUM; RABEPRAZOLE; ROSIGLITAZONE; SIMVASTATIN; TIOTROPIUM BROMIDE;

AGED; ANAMNESIS; AORTA STENOSIS; APNEA; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; BREATHING RATE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG INDICATION; DRUG RESPONSE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HUMAN; HYPERTENSION; HYPERVOLEMIA; IMAGE ANALYSIS; MITRAL VALVE REGURGITATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE RATE; REPEAT PROCEDURE; REVIEW; SMOKING; SNORING; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TREATMENT RESPONSE;

AGED; BLOOD VOLUME; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; HYPOGLYCEMIC AGENTS; THIAZOLIDINEDIONES;

EID: 68749088901     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944708093413     Document Type: Review

References (13)

1. Alpert, M.A. (2001) Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome, American Journal of the Medical Sciences. 321: 225-236.
2. American College of Cardiology. (2004) Pulmonary arterial hypertension: epidemiology, pathobiology, assessment, and therapy, J Am Coll Cardiol. 43: June supplement 1S-90S.
3. American College of Chest Physicians. (2004 ) Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines, Chest. 126: July supplement 1S-92S.
4. Atwood, Jr, C.W., McCrory, D., Garcia, J.G., Abman, S.H. and Ahearn, G.S. (2004) American College of Chest Physicians. Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines, Chest. 126(1 Suppl): 72S-77S.
5. Badesch, D.B., Abman, S.H., Simonneau, G., Rubin, L.J. and McLaughlin, V.V. (2007) Medical therapy for pulmonary arterial hypertension updated ACCP evidence-based clinical practice guidelines, Chest. 131: 1917-1928.
6. Glaxo SmithKline Pharmaceuticals. (2007) Avandia (rosiglitazone maleate). Package Insert. Research Triangle, NC, USA.
7. McGoon, M., Gutterman, D., Steen, V., Barst, R., McCrory, D.C., Fortin, T.A. et al. (2004) American college of chest physicians. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines, Chest. 126(1 Suppl): 14S-34S.
8. Mmwr. (2005) Pulmonary hypertension surveillance-United States, 1980-2002. November 11, MMWR Morb Mortal Wkly Rep. 54(SS05): 1-28.
9. Niemeyer, N.V. and Janney, L.M. (2002) Thiazolidinedione-induced edema, Pharmacotherapy. 22: 924-929.
10. Nissen, S.E. and Wolski, K. (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes, N Engl J Med. 356: 2457-2471.
11. Raskin, P., Rendell, M., Riddle, M.C., Dole, J.F., Freed, M.I. and Rosenstock, J. (2001) A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes, Diabetes Care. 24: 1226-1232.
12. Rubin, C., Egan, J. and Schacider, R. (1999) Combination therapy with pioglitazone and insulin in patients with type 2 diabetes (Abstract), Diabetes. 48(Suppl. 1): A110.
13. Wang, F., Aleksunes, L.M., Reagan, L.A. and Vergara, C.M. (2002) Management of rosiglitazone-induced edema: two case reports and a review of the literature, Diabetes Technology & Therapeutics. 4: 505-514.